Freedom Investment Management Inc. Sells 1,516 Shares of Genpact Limited $G

Freedom Investment Management Inc. reduced its stake in Genpact Limited (NYSE:GFree Report) by 11.2% in the first quarter, Holdings Channel.com reports. The institutional investor owned 12,059 shares of the business services provider’s stock after selling 1,516 shares during the period. Freedom Investment Management Inc.’s holdings in Genpact were worth $608,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. JPMorgan Chase & Co. increased its stake in shares of Genpact by 20.9% during the first quarter. JPMorgan Chase & Co. now owns 4,111,340 shares of the business services provider’s stock valued at $207,129,000 after purchasing an additional 710,704 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. bought a new position in shares of Genpact during the first quarter valued at approximately $115,807,000. Tandem Investment Advisors Inc. increased its stake in shares of Genpact by 6.6% during the first quarter. Tandem Investment Advisors Inc. now owns 2,270,143 shares of the business services provider’s stock valued at $114,370,000 after purchasing an additional 140,228 shares in the last quarter. Ameriprise Financial Inc. increased its stake in shares of Genpact by 109.8% during the first quarter. Ameriprise Financial Inc. now owns 1,615,220 shares of the business services provider’s stock valued at $81,375,000 after purchasing an additional 845,393 shares in the last quarter. Finally, Northern Trust Corp increased its stake in shares of Genpact by 5.2% during the first quarter. Northern Trust Corp now owns 1,467,849 shares of the business services provider’s stock valued at $73,950,000 after purchasing an additional 72,820 shares in the last quarter. Institutional investors own 96.03% of the company’s stock.

Genpact Price Performance

Shares of G opened at $45.11 on Wednesday. The company has a market capitalization of $7.86 billion, a P/E ratio of 14.99, a price-to-earnings-growth ratio of 1.56 and a beta of 0.92. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.32. The firm has a 50 day moving average of $44.13 and a 200 day moving average of $46.75. Genpact Limited has a twelve month low of $37.82 and a twelve month high of $56.76.

Genpact (NYSE:GGet Free Report) last announced its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The company had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.23 billion. During the same quarter last year, the firm earned $0.79 earnings per share. The firm’s quarterly revenue was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, equities research analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, September 11th will be issued a $0.17 dividend. The ex-dividend date is Thursday, September 11th. This represents a $0.68 annualized dividend and a yield of 1.5%. Genpact’s dividend payout ratio (DPR) is currently 22.59%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on G. JPMorgan Chase & Co. decreased their target price on shares of Genpact from $55.00 to $50.00 and set a “neutral” rating for the company in a research note on Wednesday, August 20th. Mizuho raised their target price on shares of Genpact from $48.00 to $51.00 and gave the company a “neutral” rating in a research note on Tuesday, July 1st. Wall Street Zen raised shares of Genpact from a “buy” rating to a “strong-buy” rating in a research note on Friday, June 6th. Robert W. Baird decreased their target price on shares of Genpact from $56.00 to $50.00 and set a “neutral” rating for the company in a research note on Thursday, May 8th. Finally, Needham & Company LLC raised their price target on shares of Genpact from $50.00 to $53.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Three investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $52.29.

View Our Latest Report on G

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Recommended Stories

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.